These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38244984)

  • 1. Emerging Themes in Genetics of Hypertrophic Cardiomyopathy: Current Status and Clinical Application.
    García-Hernández S; de la Higuera Romero L; Ochoa JP; McKenna WJ
    Can J Cardiol; 2024 May; 40(5):742-753. PubMed ID: 38244984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy in myosin-binding protein C (
    Adalsteinsdottir B; Burke M; Maron BJ; Danielsen R; Lopez B; Diez J; Jarolim P; Seidman J; Seidman CE; Ho CY; Gunnarsson GT
    Open Heart; 2020; 7(1):e001220. PubMed ID: 32341788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy.
    Ahluwalia M; Ho CY
    Heart; 2021 Feb; 107(3):183-189. PubMed ID: 33172912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
    Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
    Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
    Marian AJ; Braunwald E
    Circ Res; 2017 Sep; 121(7):749-770. PubMed ID: 28912181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy: preclinical and early phenotype.
    Ho CY
    J Cardiovasc Transl Res; 2009 Dec; 2(4):462-70. PubMed ID: 20560004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
    Keren A; Syrris P; McKenna WJ
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
    Hathaway J; Heliö K; Saarinen I; Tallila J; Seppälä EH; Tuupanen S; Turpeinen H; Kangas-Kontio T; Schleit J; Tommiska J; Kytölä V; Valori M; Muona M; Sistonen J; Gentile M; Salmenperä P; Myllykangas S; Paananen J; Alastalo TP; Heliö T; Koskenvuo J
    BMC Cardiovasc Disord; 2021 Mar; 21(1):126. PubMed ID: 33673806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and ECG variables to predict the outcome of genetic testing in hypertrophic cardiomyopathy.
    Robyns T; Breckpot J; Nuyens D; Vandenberk B; Corveleyn A; Kuiperi C; Van Aelst L; Van Cleemput J; Willems R
    Eur J Med Genet; 2020 Mar; 63(3):103754. PubMed ID: 31513939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic basis of hypertrophic cardiomyopathy.
    Lind JM; Chiu C; Semsarian C
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):927-34. PubMed ID: 17173506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy.
    Gartzonikas IK; Naka KK; Anastasakis A
    Hellenic J Cardiol; 2023; 70():65-74. PubMed ID: 36403865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.
    Arad M; Monserrat L; Haron-Khun S; Seidman JG; Seidman CE; Arbustini E; Glikson M; Freimark D
    Isr Med Assoc J; 2014 Nov; 16(11):707-13. PubMed ID: 25558701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity.
    de Feria AE; Kott AE; Becker JR
    Open Heart; 2021 Feb; 8(1):. PubMed ID: 33637569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical spectrum of preclinical hypertrophic cardiomyopathy: characterizing carriers of sarcomere gene mutation].
    Ho CY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):289-93. PubMed ID: 19791460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic considerations in hypertrophic cardiomyopathy.
    Ho CY
    Prog Cardiovasc Dis; 2012; 54(6):456-60. PubMed ID: 22687586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.
    Maron BJ; Niimura H; Casey SA; Soper MK; Wright GB; Seidman JG; Seidman CE
    J Am Coll Cardiol; 2001 Aug; 38(2):315-21. PubMed ID: 11499718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.